BRIMONIDINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C11H10BrN5
Molecular Weight	292.135
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of BRIMONIDINE

Structure Search

SMILES

BrC1=C(NC2=NCCN2)C=CC3=C1N=CC=N3

InChI

InChIKey=XYLJNLCSTIOKRM-UHFFFAOYSA-N

InChI=1S/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17)

HIDE SMILES / InChI

Molecular Formula	C11H10BrN5
Molecular Weight	292.135
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:59:41 UTC 2023` Edited by `admin` on `Fri Dec 15 15:59:41 UTC 2023`
Record UNII	E6GNX3HHTE
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BRIMONIDINE

Official Name

English

AGN-190342 FREE BASE

Code

English

5-BROMO-6-(2-IMIDAZOLIN-2-YLAMINO)QUINOXALINE D-TARTRATE (1:1).

Systematic Name

English

BRIMONIDINE [VANDF]

Common Name

English

UK-1430418 FREE BASE

Code

English

brimonidine [INN]

Common Name

English

6-QUINOXALINAMINE, 5-BROMO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-, (S-(R*,R*))-2,3-DIHYDROXYBUTANEDIOATE (1:1)

Systematic Name

English

Brimonidine [WHO-DD]

Common Name

English

UK-14304

Code

English

BRIMONIDINE [MI]

Common Name

English

NSC-318825

Code

English

Classification Tree Code System Code

WHO-VATC

QS01EA05

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

WHO-ATC

S01EA05

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

WHO-VATC

QD11AX21

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

NCI_THESAURUS

C29709

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

FDA ORPHAN DRUG

564016

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

FDA ORPHAN DRUG

125699

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

WHO-ATC

D11AX21

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

NDF-RT

N0000175552

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

NDF-RT

N0000000209

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

NCI_THESAURUS

C29705

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

Code System Code Type Description

PUBCHEM

2435

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

DRUG BANK

DB00484

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

IUPHAR

520

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

SMS_ID

100000088662

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

NSC

318825

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

DAILYMED

E6GNX3HHTE

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

LACTMED

Brimonidine

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

MERCK INDEX

m2651

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

Merck Index

WIKIPEDIA

BRIMONIDINE

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

EVMPD

SUB05889MIG

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

FDA UNII

E6GNX3HHTE

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

NCI_THESAURUS

C65269

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

EPA CompTox

DTXSID3045221

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

INN

6863

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

CAS

59803-98-4

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

DRUG CENTRAL

395

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

CHEBI

3175

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

ChEMBL

CHEMBL844

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

MESH

C015620

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

RXCUI

134615

Created by admin on Fri Dec 15 15:59:41 UTC 2023 , Edited by admin on Fri Dec 15 15:59:41 UTC 2023

PRIMARY

RxNorm

Related Record Type Details


					4S9CL2DY2H

BRIMONIDINE TARTRATE

SALT/SOLVATE -> PARENT


					50U1BO5G5P

ALPHA-2A ADRENERGIC RECEPTOR

TARGET -> AGONIST

Interaction Type:

SHORT-ACTING

Related Record Type Details


					RUP9M72QDH

5-BROMO-6-(IMIDAZOLIDIN-2-YLIDENEAMINO)-3H-QUINOXALIN-2-ONE

METABOLITE -> PARENT


					2B90TM0L9V

8-BROMO-7-(IMIDAZOLIDIN-2-YLIDENEAMINO)-3H-QUINOXALIN-2-ONE

METABOLITE -> PARENT

Related Record Type Details


					9WA6NGH9DR

N-(2-AMINOETHYL)-N'-(5-BROMO-6-QUINOXALINYL)THIOUREA

IMPURITY -> PARENT

Amount:

Related Record Type Details


					E6GNX3HHTE

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC